Advertisement
Canada markets closed
  • S&P/TSX

    22,167.03
    +59.95 (+0.27%)
     
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • DOW

    39,807.37
    +47.29 (+0.12%)
     
  • CAD/USD

    0.7380
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    83.11
    -0.06 (-0.07%)
     
  • Bitcoin CAD

    95,114.23
    -859.35 (-0.90%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,254.80
    +16.40 (+0.73%)
     
  • RUSSELL 2000

    2,124.55
    +10.20 (+0.48%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,379.46
    -20.06 (-0.12%)
     
  • VOLATILITY

    13.01
    0.00 (0.00%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • CAD/EUR

    0.6838
    -0.0005 (-0.07%)
     

Today's Research Reports on CardioComm Solutions, Cipher Pharmaceuticals, Medicure and Aphria

NEW YORK, NY / ACCESSWIRE / January 17, 2019 / The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.

The Market Edge Initiates Coverage on:

CardioComm Solutions, Inc.
https://marketedgereport.com/report/EKG.V/

Cipher Pharmaceuticals Inc.
https://marketedgereport.com/report/CPH.TO/

Medicure Inc.
https://marketedgereport.com/report/MPH.V/

Aphria Inc.
https://marketedgereport.com/report/APHA.TO/

ADVERTISEMENT

CardioComm Solutions' stock moved 11.11% lower Wednesday, to close the day at $0.04. The stock recorded a trading volume of 27,000 shares, which was below its three months average volume of 123,790 shares. In the last year, CardioComm Solutions' shares have traded in a range of 0.04 - 0.07. The share price has fallen 0% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.04 is lower than its 200-day moving average of $0.05.

Access The Market Edge's CardioComm Solutions, Inc. Research Report:
https://marketedgereport.com/report/EKG.V/

On Wednesday, shares of Cipher Pharmaceuticals recorded a trading volume of 141,863 shares, which was above the three months average volume of 44,809 shares. The stock ended the day 5.61% higher at $2.07. The share price has fallen 60.8% from its 52 week high with a 52 week trading range of 1.62 - 5.28. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $1.86 is lower than its 200-day moving average of $2.61. Shares of the company are trading at a Price to Earnings ratio of 10.30. Shares of Cipher Pharmaceuticals have gained approximately 23.21 percent year-to-date.

Access The Market Edge's Cipher Pharmaceuticals Inc. Research Report:
https://marketedgereport.com/report/CPH.TO/

Medicure's stock moved 2.36% lower Wednesday, to close the day at $6.20. The stock recorded a trading volume of 8,703 shares, which was below its three months average volume of 12,160 shares. In the last year, Medicure's shares have traded in a range of 5.56 - 7.55. The share price has gained 11.51% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.20 is lower than its 200-day moving average of $6.67. Shares of the company are trading at a Price to Earnings ratio of 2.07. Shares of Medicure have gained approximately 0.98 percent year-to-date.

Access The Market Edge's Medicure Inc. Research Report:
https://marketedgereport.com/report/MPH.V/

On Wednesday, shares of Aphria recorded a trading volume of 4,709,633 shares, which was below the three months average volume of 11,194,024 shares. The stock ended the day 0.68% lower at $8.80. The share price has fallen 60% from its 52 week high with a 52 week trading range of 4.76 - 22.00. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $8.11 is lower than its 200-day moving average of $13.07. Shares of the company are trading at a Price to Earnings ratio of 22.11. Shares of Aphria have gained approximately 3.29 percent year-to-date.

Access The Market Edge's Aphria Inc. Research Report:
https://marketedgereport.com/report/APHA.TO/

Our Actionable Research on CardioComm Solutions, Inc. (TSXV :EKG.V), Cipher Pharmaceuticals Inc. (TSX :CPH.TO), Medicure Inc. (TSXV :MPH.V) and Aphria Inc. (TSX :APHA.TO) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: The Market Edge